| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate |
2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41af33a7a3863d49614702c35b4b0995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f48e8aa6f9e0a21b3e0481333824dd6 |
| publicationDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005069587-A1 |
| titleOfInvention |
Novel drug compositions and dosage forms of topiramate |
| abstract |
The present invention is directed to novel drug compositions and dosage forms comprising said drug compositions. The drug compositions of the present invention comprise a pharmaceutical agent and a solubilizing agent. The drug compositions of the present invention are particularly advantageous for use with low solubility and/or low dissolution rate pharmaceutical agents. The present invention is further directed to methods for manufacturing of said drug compositions and dosage forms. The present invention is further directed to methods of treatment comprising administration of said drug compositions and dosage forms. The present invention further provides topiramate drug compositions, dosage forms and methods of treatment which provide a reduction in the frequency and/or severity of at least one adverse event associated with topiramate treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877248-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9622983-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016151332-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011071805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8992989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10314790-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008118557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011053999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010328375-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013195988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008131501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012244217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I490209-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008085306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9326971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101464053-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007190137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298576-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9555004-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9744137-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9173850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549940-B2 |
| priorityDate |
2003-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |